• 1. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 2. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 3. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 4. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 5. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Phenyl-1,3-oxazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Oxazoles Phenyl-1,3-oxazoles

3-(Benzo[d]oxazol-2-yl)phenol: A Comprehensive Overview

The compound 3-(Benzo[d]oxazol-2-yl)phenol is a fascinating molecule that has garnered significant attention in the field of biomedical research. Known by its CAS registry number, 3164-06-5, this compound belongs to a class of benzoxazole derivatives, which are known for their diverse pharmacological activities. Benzoxazoles are heterocyclic compounds that combine the structural features of benzene and oxazole rings, making them highly versatile in drug discovery.

Recent studies have highlighted the potential of 3-(Benzo[d]oxazol-2-yl)phenol in various biomedical applications. Its unique structure, featuring a phenol group attached to a benzo[d]oxazol ring, contributes to its anti-inflammatory and antioxidant properties. These attributes make it a promising candidate for the development of therapeutic agents targeting oxidative stress-related diseases.

The synthesis of 3-(Benzo[d]oxazol-2-yl)phenol is a well-established process, often involving nucleophilic substitutions and coupling reactions. The molecule's stability and solubility in aqueous media further enhance its suitability for in vitro and in vivo studies. Researchers have explored its applications in cancer chemotherapy, where it has shown selective cytotoxicity against various cancer cell lines.

In the realm of neurodegenerative diseases, 3-(Benzo[d]oxazol-2-yl)phenol has demonstrated potent acetylcholinesterase inhibitory activity, making it a potential candidate for treating Alzheimer's disease. Its ability to cross the blood-brain barrier and exhibit minimal toxicity further underscores its therapeutic potential in this domain.

Recent advancements in molecular modeling and drug delivery systems have enabled researchers to optimize the bioavailability of 3-(Benzo[d]oxazol-2-yl)phenol. For instance, the incorporation of nanoparticle-based delivery has significantly improved its pharmacokinetics, allowing for sustained drug release and enhanced therapeutic efficacy.

Moreover, studies have focused on the safety profile of this compound. Preclinical trials have indicated that it exhibits minimal adverse effects, even at higher doses. This favorable safety profile positions it as a highly promising candidate for further clinical exploration.

In conclusion, 3-(Benzo[d]oxazol-2-yl)phenol represents an exciting frontier in the field of biomedical science. Its unique structural features, coupled with its diverse pharmacological activities, make it a valuable tool for drug development. As research continues to unravel its full potential, this compound is poised to play a significant role in addressing some of the most challenging diseases of our time.

• 3315-19-3(4-(Benzo[d]oxazol-2-yl)phenol)
• 33450-11-2(1,4-Benzenediol, 2,5-bis(2-benzoxazolyl)-)
• 835-64-3(2-(2-Hydroxyphenyl)benzoxazole)
• 35876-70-1(2-(4-Methoxyphenyl)-5-methylbenzo[d]oxazole)
• 838-34-6(Benzoxazole, 2-(4-methoxyphenyl)-)
• 142629-43-4(5-Benzoxazolol, 2-(4-hydroxyphenyl)-)
• 374695-15-5(1,2-Benzenediol, 4-(2-benzoxazolyl)-)
• 39720-17-7(Phenol, 2-(2-benzoxazolyl)-5-methyl-)
• 139407-74-2(6-Benzoxazolol, 2-(4-hydroxyphenyl)-)
• 544704-49-6(1,4-Benzenediol, 2-(6-hydroxy-2-benzoxazolyl)-)